glp-1 neuroinflammation Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders Role of glucagon-like peptide-1 receptor
Description
Some patients benefit from combination therapy with both classes
CEO David Joyner said
Brain 140, 14201436
Injured hepatocytes release Pathogen-Associated Molecular Patterns (PAMPs) and Damage-Associated Molecular Patterns (DAMPs) activate immune responses and recruit Kupffer cells, HSCs, and other immune cells to promote inflammation and fibrosis through cytokine signaling
Maybe you're on YouTube, you can hit subscribe
Liu W, Luo Z, Zhou J et al
